Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
出版年份 2018 全文链接
标题
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume -, Issue -, Pages 1-16
出版商
Informa UK Limited
发表日期
2018-09-22
DOI
10.1080/14728222.2018.1526925
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aging-associated changes in hippocampal glycogen metabolism in mice. Evidence for and against astrocyte-to-neuron lactate shuttle
- (2018) Dominika Drulis-Fajdasz et al. GLIA
- Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity
- (2018) Jee Hyun Yi et al. NEUROPHARMACOLOGY
- The effect of chronic stimulation of serotonin receptor type 7 on recognition, passive avoidance memory, hippocampal long-term potentiation, and neuronal apoptosis in the amyloid β protein treated rat
- (2018) Siamak Shahidi et al. PSYCHOPHARMACOLOGY
- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- Interactions Between Variation in Candidate Genes and Environmental Factors in the Etiology of Schizophrenia and Bipolar Disorder: a Systematic Review
- (2017) Błażej Misiak et al. MOLECULAR NEUROBIOLOGY
- Glucocorticoid-mediated activation of GSK3β promotes tau phosphorylation and impairs memory in type 2 diabetes
- (2017) Aditi Dey et al. NEUROBIOLOGY OF AGING
- Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3β) and NF-κB/p65 signalling
- (2017) Qiong Cao et al. PLoS One
- Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis
- (2017) Alexandre Vallée et al. Oncotarget
- Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer’s Disease
- (2017) Emiliano Peña-Altamira et al. Frontiers in Aging Neuroscience
- GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
- (2017) Agata Gozdz et al. Frontiers in Molecular Neuroscience
- Memantine Inhibits Calpain-Mediated Truncation of GSK-3 Induced by NMDA: Implications in Alzheimer's Disease
- (2017) Paloma Goñi-Oliver et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis
- (2017) Helena P.G. Joaquim et al. SCHIZOPHRENIA RESEARCH
- Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity
- (2016) Zhao-xiang Ren et al. ACTA PHARMACOLOGICA SINICA
- Early effects of Aβ 1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways
- (2016) Fabiana Morroni et al. BEHAVIOURAL BRAIN RESEARCH
- Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
- (2016) Mudasir Maqbool et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11 month old APP/PS1 transgenic mice: A Western blot study
- (2016) Zhao-Xu Zhang et al. EXPERIMENTAL GERONTOLOGY
- GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation
- (2016) M. Pardo et al. GENES BRAIN AND BEHAVIOR
- Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia
- (2016) Mohammed Garba Magaji et al. METABOLIC BRAIN DISEASE
- Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition
- (2016) Makoto Tamura et al. NEURON
- Nucleotides in neuroregeneration and neuroprotection
- (2016) M. Teresa Miras-Portugal et al. NEUROPHARMACOLOGY
- Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex
- (2016) Yan-Chun Li et al. NEUROPHARMACOLOGY
- A unique type of GSK-3 inhibitor brings new opportunities to the clinic
- (2016) A. Licht-Murava et al. Science Signaling
- Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
- (2016) Mukesh K. Pandey et al. Theranostics
- Age-Dependent Switch of the Role of Serotonergic 5-HT1AReceptors in Gating Long-Term Potentiation in Rat Visual CortexIn Vivo
- (2016) Peter J. Gagolewicz et al. NEURAL PLASTICITY
- A unique type of GSK-3 inhibitor brings new opportunities to the clinic
- (2016) A. Licht-Murava et al. Science Signaling
- Neuroprotective effect of resveratrol against brain ischemia reperfusion injury in rats entails reduction of DJ-1 protein expression and activation of PI3K/Akt/GSK3b survival pathway
- (2016) Ghada A. Abdel-Aleem et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Resveratrol Supplementation Did Not Improve Cognition in Patients with Schizophrenia: Results from a Randomized Clinical Trial
- (2016) Karine Zortea et al. Frontiers in Psychiatry
- Activation of Muscarinic M1 Acetylcholine Receptors Induces Long-Term Potentiation in the Hippocampus
- (2015) Siobhan H. Dennis et al. CEREBRAL CORTEX
- Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2
- (2015) Jemeen Sreedharan et al. CURRENT BIOLOGY
- Activation of m1 muscarinic acetylcholine receptor induces surface transport of KCNQ channels through a CRMP-2-mediated pathway
- (2015) L. Jiang et al. JOURNAL OF CELL SCIENCE
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
- (2015) Yu Tang et al. MOLECULAR NEUROBIOLOGY
- A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
- (2015) R. Scott Turner et al. NEUROLOGY
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Involvement of cellular metabolism in age-related LTP modifications in rat hippocampal slices
- (2015) Dominika Drulis-Fajdasz et al. Oncotarget
- Lentiviral silencing of GSK-3β in adult dentate gyrus impairs contextual fear memory and synaptic plasticity
- (2015) Benjamin Chew et al. Frontiers in Behavioral Neuroscience
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes
- (2014) Tiago Silva et al. AGEING RESEARCH REVIEWS
- Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3β Inhibitors
- (2014) Federica Prati et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein
- (2014) J J Credle et al. CELL DEATH AND DIFFERENTIATION
- Myelination, oligodendrocytes, and serious mental illness
- (2014) V. Haroutunian et al. GLIA
- Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses
- (2014) Lion Shahab et al. HIPPOCAMPUS
- Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?
- (2014) Marie Gibbs METABOLIC BRAIN DISEASE
- Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin
- (2014) S M Ochs et al. MOLECULAR PSYCHIATRY
- Synaptic recruitment of gephyrin regulates surface GABAA receptor dynamics for the expression of inhibitory LTP
- (2014) Enrica Maria Petrini et al. Nature Communications
- Alpha-synuclein biology in Lewy body diseases
- (2014) Woojin Scott Kim et al. Alzheimers Research & Therapy
- Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H2O2
- (2013) Ye Feng et al. JOURNAL OF NEUROCHEMISTRY
- β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3
- (2013) Yulei Deng et al. NEUROBIOLOGY OF AGING
- Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments
- (2013) Margaret K. King et al. PHARMACOLOGY & THERAPEUTICS
- GSK3B and MAPT Polymorphisms Are Associated with Grey Matter and Intracranial Volume in Healthy Individuals
- (2013) Carol Dobson-Stone et al. PLoS One
- Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine
- (2013) Daniel Hernandez-Baltazar et al. PLoS One
- FLZ Alleviates the Memory Deficits in Transgenic Mouse Model of Alzheimer’s Disease via Decreasing Beta-Amyloid Production and Tau Hyperphosphorylation
- (2013) Xiu-Qi Bao et al. PLoS One
- Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
- (2012) J. A. Morales-García et al. ACS Chemical Neuroscience
- Accumulation of Toxic -Synuclein Oligomer within Endoplasmic Reticulum Occurs in -Synucleinopathy In Vivo
- (2012) E. Colla et al. JOURNAL OF NEUROSCIENCE
- Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
- (2012) Siva Sundara Kumar Durairajan et al. NEUROBIOLOGY OF AGING
- Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
- (2012) George Bartzokis NEUROPHARMACOLOGY
- Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase
- (2012) Norelle C. Wildburger et al. Frontiers in Molecular Neuroscience
- Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation
- (2011) Akinobu Suzuki et al. CELL
- Long-term plasticity at inhibitory synapses
- (2011) Pablo E Castillo et al. CURRENT OPINION IN NEUROBIOLOGY
- GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules
- (2011) E.-M. Hur et al. GENES & DEVELOPMENT
- Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells
- (2011) Sigalit Nahman et al. Innate Immunity
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice
- (2011) W. Timothy O’Brien et al. JOURNAL OF CLINICAL INVESTIGATION
- Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
- (2011) Mei-Jen Wang et al. Journal of Neuroinflammation
- A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
- (2011) Jean-Martin Beaulieu JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
- (2011) Haythum O. Tayeb et al. PHARMACOLOGY & THERAPEUTICS
- Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways
- (2011) E. M. Wexler et al. Science Signaling
- Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
- (2011) Abigail M. Polter et al. Frontiers in Molecular Neuroscience
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- Glycogen Synthase Kinase-3 Is an Early Determinant in the Differentiation of Pathogenic Th17 Cells
- (2010) E. Beurel et al. JOURNAL OF IMMUNOLOGY
- GSK3 Regulates Myelin-Dependent Axon Outgrowth Inhibition through CRMP4
- (2010) Y. Z. Alabed et al. JOURNAL OF NEUROSCIENCE
- GSK-3 Inhibits Presynaptic Vesicle Exocytosis by Phosphorylating P/Q-Type Calcium Channel and Interrupting SNARE Complex Formation
- (2010) L.-Q. Zhu et al. JOURNAL OF NEUROSCIENCE
- Regulation of GSK3 isoforms by phosphatases PP1 and PP2A
- (2010) Félix Hernández et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles
- (2010) Emma L Clayton et al. NATURE NEUROSCIENCE
- Inhibition of neuronal calcium oscillations by cell surface APP phosphorylated on T668
- (2010) Susana Ferrao Santos et al. NEUROBIOLOGY OF AGING
- M1 Muscarinic Receptors Boost Synaptic Potentials and Calcium Influx in Dendritic Spines by Inhibiting Postsynaptic SK Channels
- (2010) Andrew J. Giessel et al. NEURON
- Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells
- (2010) Christian Lange et al. NEUROSCIENCE LETTERS
- GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism
- (2010) Marjelo A. Mines et al. PLoS One
- Regulation of GABAergic synapse formation and plasticity by GSK3 -dependent phosphorylation of gephyrin
- (2010) S. K. Tyagarajan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling
- (2009) Yingwei Mao et al. CELL
- Nonprimed and DYRK1A-primed GSK3 -phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons
- (2009) T. M. E. Scales et al. JOURNAL OF CELL SCIENCE
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells
- (2009) Yeni Kim et al. JOURNAL OF NEUROCHEMISTRY
- Lithium Treatment Decreases Activities of Tau Kinases in a Murine Model of Senescence
- (2009) Marta Tajes et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
- (2009) L. Serenó et al. NEUROBIOLOGY OF DISEASE
- Expression QTL and regulatory network analysis of microtubule-associated protein tau gene
- (2009) Qin Shen et al. PARKINSONISM & RELATED DISORDERS
- Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
- (2009) Agnès Petit-Paitel et al. PLoS One
- Akt/GSK3 Signaling in the Action of Psychotropic Drugs
- (2008) Jean-Martin Beaulieu et al. Annual Review of Pharmacology and Toxicology
- Upregulation of GSK3β expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)
- (2008) Wencheng Yang et al. BRAIN RESEARCH
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
- (2008) Christopher J. Yuskaitis et al. CELLULAR SIGNALLING
- Glycogen Synthase Kinase (GSK) 3β Directly Phosphorylates Serine 212 in the Regulatory Loop and Inhibits Microtubule Affinity-regulating Kinase (MARK) 2
- (2008) Thomas Timm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
- (2008) Eléonore Beurel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-β-induced neuronal cell death
- (2008) Min-Young Noh et al. JOURNAL OF NEUROCHEMISTRY
- GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
- (2008) Shuxin Hu et al. NEUROBIOLOGY OF DISEASE
- Glycogen synthase kinase-3beta is associated with Parkinson's disease
- (2008) Masahiro Nagao et al. NEUROSCIENCE LETTERS
- Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: Novel cytoprotective mechanism against oxidative damage
- (2008) Ju Hee Lim et al. PHARMACOLOGICAL RESEARCH
- Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3 Inactivation
- (2008) T. M. Thornton et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started